BioXcel Therapeutics, Inc. SEC filings BTAIQ
BioXcel Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Nov 13, 2017. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (acquisition or sale of assets, officer or director change, bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Bylaw or fiscal year change
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
New debt, Listing notice
|
Sep 1, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Material agreement, Bankruptcy
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 25, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 24, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 3 | Initial insider ownership | Aug 14, 2026 | Aug 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 11, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 6, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 4, 2026 |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 1, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Apr 17, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Other events
|
Apr 1, 2026 | Apr 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 30, 2026 | — |
| S-8 | Employee stock plan registration | Mar 27, 2026 | — |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 14, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 11, 2026 | Mar 10, 2026 |
| 424B5 | Prospectus supplement | Mar 11, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 12, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 6, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Other events
|
Jan 20, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 14, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 15, 2025 | Dec 12, 2025 |
| ARS | Annual report to shareholders | Nov 12, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Nov 12, 2025 | Dec 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Nov 3, 2025 | Oct 31, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 31, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Oct 14, 2025 |
| 4 | Insider transaction | Oct 1, 2025 | Sep 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 1, 2025 | — |
| 4 | Insider transaction | Sep 16, 2025 | Sep 14, 2025 |
| 4 | Insider transaction | Sep 16, 2025 | Sep 14, 2025 |
| 4 | Insider transaction | Sep 16, 2025 | Sep 14, 2025 |
| 4 | Insider transaction | Sep 16, 2025 | Sep 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 4 | Insider transaction | Sep 2, 2025 | Aug 31, 2025 |
| 8-K |
Current report
Other events
|
Aug 27, 2025 | Aug 27, 2025 |
| 424B5 | Prospectus supplement | Aug 18, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Other events
|
Aug 15, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Other events
|
Aug 6, 2025 | Aug 6, 2025 |
| 424B5 | Prospectus supplement | Aug 6, 2025 | — |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Other events
|
Aug 1, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Jul 31, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Other events
|
Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 14, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 14, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 14, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 14, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 31, 2025 |
| 8-K |
Current report
Other events
|
May 27, 2025 | May 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| S-8 | Employee stock plan registration | Apr 4, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 3, 2025 | Apr 3, 2025 |
| 424B5 | Prospectus supplement | Apr 3, 2025 | — |
| 4 | Insider transaction | Apr 1, 2025 | Jul 22, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Jul 22, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Jul 22, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Jul 22, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Jul 22, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Jul 22, 2024 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 21, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 21, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 4, 2025 | Mar 3, 2025 |
| 424B5 | Prospectus supplement | Mar 4, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 3, 2025 | Feb 28, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 6, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jan 29, 2025 | Jan 28, 2025 |
| EFFECT | Filing | Jan 17, 2025 | — |
| 4 | Insider transaction | Jan 16, 2025 | Jan 15, 2025 |
| 3 | Initial insider ownership | Jan 16, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2025 | Jan 15, 2025 |
| CORRESP | Letter to the SEC | Jan 15, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2025 | — |
| 4 | Insider transaction | Jan 10, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 7, 2025 |
| S-3 | Shelf registration | Jan 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Dec 30, 2024 | Jan 28, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 18, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 18, 2024 | — |
| PRE 14A | Preliminary proxy statement | Dec 18, 2024 | Jan 28, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 14, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 14, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 14, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 14, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 14, 2024 |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144/A | Filing | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 144 | Notice of proposed sale | Dec 16, 2024 | — |
| 4/A | Ownership document | Dec 4, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 3 | Initial insider ownership | Nov 25, 2024 | Nov 21, 2024 |
| 424B5 | Prospectus supplement | Nov 25, 2024 | — |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Nov 21, 2024 | Nov 21, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Sep 17, 2024 |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 8-K |
Current report
Listing notice
|
Sep 20, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Sep 19, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 14, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 14, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 14, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 14, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 14, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 15, 2024 |
| 4/A | Ownership document | Sep 17, 2024 | Jun 15, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BTAIQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1720893
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.